Trials / Withdrawn
WithdrawnNCT01615627
Hypotonic Treprostinil Subcutaneous Infusion for Control of Treprostinil Related Site Pain
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Jewish General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators will test whether hypotonic (diluted) remodulin solution causes less pain than the eutonic (undiluted) solution supplied by the manufacturer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HypotonicTreprostinil Solution | Hypotonic Treprostinil Solution |
| DRUG | Eutonic Treprostinil Solution | Eutonic Treprostinil Solution |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2019-02-28
- Completion
- 2019-02-28
- First posted
- 2012-06-08
- Last updated
- 2020-03-03
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01615627. Inclusion in this directory is not an endorsement.